跳至主要内容
临床试验/CTRI/2023/10/059117
CTRI/2023/10/059117招募中Unknown

Study on the effectiveness of 12.5 % dextrose with 2 % lignocaine (Prolotherapy) in comparison to 2% lignocaine alone in ultrasound-guided trigger point injection in the management of Myofascial pain dysfunction syndrome- Single blinded randomized control trial

aqoosh Haidry0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pure cases of MPDS without any joint pain
  • MPDS in the masseter and temporalis muscle
  • At least one active myofascial trigger point in the masseter and temporalis muscle
  • Age-18 to 65 years old
  • Cases who are not receiving any physical therapy or medication to relieve pain.
  • MPDS cases non -respondent to other therapy

排除标准

  • Cases of MPDS with temporomandibular joint pain.
  • Active inflammatory, rheumatic, or infectious disease of TMJ
  • Those who use anticoagulants, those with bleeding diathesis
  • Patients diagnosed with fibromyalgia or other common musculoskeletal pain syndromes
  • Patients with a history of panic attacks
  • Those who are allergic to local anesthetic drug
  • Those who are pregnant
  • Patient with vitamin D deficiency

研究者

发起方
aqoosh Haidry

相似试验